While President Donald Trump has repeatedly said the prices of prescription drugs would be lowered under deals with drugmakers, a Thursday analysis released by Vermont Sen. Bernie Sanders suggests that has not been the case.
All but one of the 16 drugmakers involved in the TrumpRx project have continued to increase their prices since the deals were struck late last year and all of the companies have raised the prices of 337 drugs since January 21, 2025, the 11-page report shared with The Independent – which cites data from the price tracking software NAVLIN – shows.